About: SARS Unique Domain (SUD) of Severe Acute Respiratory Syndrome Coronavirus Induces NLRP3 Inflammasome-Dependent CXCL10-Mediated Pulmonary Inflammation

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: SARS Unique Domain (SUD) of Severe Acute Respiratory Syndrome Coronavirus Induces NLRP3 Inflammasome-Dependent CXCL10-Mediated Pulmonary Inflammation Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	SARS Unique Domain (SUD) of Severe Acute Respiratory Syndrome Coronavirus Induces NLRP3 Inflammasome-Dependent CXCL10-Mediated Pulmonary Inflammation
Creator	Lin, Cheng-Wen Huang, Su-Hua Chang, Hsin-Hou Chang, Young-Sheng Ko, Bo-Han Ju, Jyh-Cherng
Source	Medline; PMC
abstract	Severe acute respiratory syndrome–associated coronavirus (SARS-CoV) initiates the cytokine/chemokine storm-mediated lung injury. The SARS-CoV unique domain (SUD) with three macrodomains (N, M, and C), showing the G-quadruplex binding activity, was examined the possible role in SARS pathogenesis in this study. The chemokine profile analysis indicated that SARS-CoV SUD significantly up-regulated the expression of CXCL10, CCL5 and interleukin (IL)-1β in human lung epithelial cells and in the lung tissues of the mice intratracheally instilled with the recombinant plasmids. Among the SUD subdomains, SUD-MC substantially activated AP-1-mediated CXCL10 expression in vitro. In the wild type mice, SARS-CoV SUD-MC triggered the pulmonary infiltration of macrophages and monocytes, inducing CXCL10-mediated inflammatory responses and severe diffuse alveolar damage symptoms. Moreover, SUD-MC actuated NOD-, LRR- and pyrin domain-containing protein 3 (NLRP3) inflammasome-dependent pulmonary inflammation, as confirmed by the NLRP3 inflammasome inhibitor and the NLRP3(−/−) mouse model. This study demonstrated that SARS-CoV SUD modulated NLRP3 inflammasome-dependent CXCL10-mediated pulmonary inflammation, providing the potential therapeutic targets for developing the antiviral agents.
has issue date	2020-04-30(xsd:dateTime)
bibo:doi	10.3390/ijms21093179
bibo:pmid	32365944
has license	cc-by
sha1sum (hex)	eac23f0f9398a50912a215d05521dce9c78ec3e8
schema:url	https://doi.org/10.3390/ijms21093179
resource representing a document's title	SARS Unique Domain (SUD) of Severe Acute Respiratory Syndrome Coronavirus Induces NLRP3 Inflammasome-Dependent CXCL10-Mediated Pulmonary Inflammation
has PubMed Central identifier	PMC7247444
has PubMed identifier	32365944
schema:publication	Int J Mol Sci
resource representing a document's body	covid:eac23f0f9398a50912a215d05521dce9c78ec3e8#body_text
is schema:about of	named entity 'domain' named entity 'mice' named entity 'acute' named entity 'profile' named entity 'SUD' named entity 'triggered' named entity 'inhibitor' named entity 'pulmonary' named entity 'mediated' named entity 'tissues' named entity 'DEMONSTRATED' named entity 'SYMPTOMS' named entity 'SEVERE ACUTE RESPIRATORY SYNDROME' named entity 'ACTIVATED' named entity 'AP-1' named entity 'DOMAIN' named entity 'SARS-COV' named entity 'CORONAVIRUS' covid:arg/eac23f0f9398a50912a215d05521dce9c78ec3e8 named entity 'CCL5' named entity 'severe' named entity 'diffuse alveolar damage' named entity 'study' named entity 'pulmonary' named entity 'lung' named entity 'therapeutic' named entity 'plasmids' named entity 'mediated' named entity 'SUD' named entity 'binding activity' named entity 'lung' named entity 'AP-1' named entity 'NLRP3' named entity 'Severe acute respiratory syndrome' named entity 'SARS-CoV' named entity 'CCL5' named entity 'inflammasome' named entity 'up-regulated' named entity 'CXCL10' named entity 'NLRP3' named entity 'interleukin' named entity 'SARS-CoV' named entity 'CXCL10' named entity 'lung injury' named entity 'mice' named entity 'inflammation' named entity 'wild type' named entity 'monocytes' named entity 'diffuse alveolar damage' named entity 'expression' named entity 'symptoms' named entity 'epithelial cells' named entity 'pathogenesis' named entity 'plasmids' named entity 'pyrin domain' named entity 'CXCL10' named entity 'inflammatory responses' named entity 'NOD' named entity 'Inflammasome' named entity 'therapeutic targets' named entity 'G-quadruplex' named entity 'SARS-CoV' named entity 'LRR' named entity 'coronavirus' named entity 'SARS' named entity 'mice' named entity 'recombinant' named entity 'Inflammation' named entity 'cytokine' named entity 'NLRP3' named entity 'inflammasome' named entity 'CXCL10' named entity 'Severe Acute Respiratory Syndrome Coronavirus' named entity 'INFLAMMASOME' named entity 'PROVIDING' named entity 'EXPRESSION'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software